ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel’s Registrational Path to Potential Approval in the U.S. GlobeNewswire Sep 3, 2024 11:30am
ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference GlobeNewswire Aug 27, 2024 11:30am
ProKidney Reports Business Updates and Second Quarter 2024 Financial Results GlobeNewswire Aug 9, 2024 11:00am